News

First-of-its-kind Briefing for Congress on Glioblastoma On the heels of our annual advocacy day on Capitol Hill in Washington, D.C., Head to the Hill, where we bring volunteers from across the country to speak with members of Congress about the policies and bills that the brain tumor community would like to see policymakers support, National Brain Tumor Society (NBTS) held a […] May 22, 2018

Brain Tumor Research Highlights: March 2018 Over the years, NBTS has given nearly $40 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship research projects – like the Defeat GBM (glioblastoma) Research Collaborative – […] March 23, 2018

A Pioneer’s Story: Years of Discoveries and Commitment to Brain Tumor Patients When the National Brain Tumor Society’s legacy organizations – The Brain Tumor Society (BTS) and the National Brain Tumor Foundation (NBTF) – were founded in the 1980’s, brain tumor research was still, in essence, in its infancy. Very little was understood about the underlying biology of these tumors or, subsequently, how to treat them. Thus, […] December 21, 2017

Beating the Odds Thanks to Research Funding: Greg’s Story After an otherwise-healthy and vibrant 24-year old newlywed was diagnosed with an aggressive brain tumor and given just two-to-three years to live, a new clinical trial – based on NBTS-funded research – provided hope and helped beat the odds. “Temozolomide is what it is: a chemotherapy,” says Greg. “This means constantly feeling drained of your […] November 13, 2017

Guest Blog: The Powerful Platform Offered by National Brain Tumor Society “It is very unlikely that you will not have a recurrence,” my neuro-oncologist said softly, leaning in to fold his hands together, interlocking his fingers, “but you have many positive prognostic indicators in your favor, including your age, IDH1 mutation status, and general good health.” With this information—vague and uncertain to a newly diagnosed patient, […] November 7, 2017